Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite

Journal of the American College of Cardiology

Volumn 33, Issue 4, 1999, Pages 1062-1070

  Flesch, Markus ^a   Kilter, Heiko ^a   Cremers, Bodo ^a   Laufs, Ulrich ^a   Südkamp, Michael ^a   Ortmann, Monika ^a   Müller, Frank U ^b   Böhm, Michael ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; HEMOGLOBIN; ISOPRENALINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; TIRON;

ADULT; ARTICLE; ENZYME ACTIVITY; FEMALE; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INOTROPISM; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY;

ADULT; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0033558704     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00660-3     Document Type: Article

References (40)

1. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
2. Parker MM, Natanson C, Suifredini AF, et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990;113:227-42.
3. Parillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock. J Clin Invest 1985;76:1539-53.
4. Weitzberg E, Lundberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991;33:222-7.
5. Böhm M, Kirchmayr R, Gierschik P, Erdmann E. Increase of myocardial inhibitory G-proteins in catecholamine refractory septic shock or in septic multiorgan failure. Am J Med 1995;98:183-6.
6. Reithmann C, Hallström S, Pilz G, Kapsner T, Schlag G, Werdan K. Desensitisation of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock. Circ Shock 1993;41:48-59.
7. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res 1996;79:363-80.
8. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
9. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992;263:H1963-6.
10. Balligand J-L, Ungureanu D, Kelly RA, et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993;91:2314-9.
11. Balligand J-L, Ungureanu-Langrois D, Simmons WW, et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 1994;269:27580-8.
12. Harding P, Carretero OA, LaPointe MC. Effects of interleukin 1-β and nitric oxide on cardiac myocytes. Hypertension 1995;25:421-30.
13. Shindo T, Ikeda U, Ohkawa F, et al. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 1995;29:813-9.
14. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 1996;28:1631-9.
15. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993;26S:H176-82.
16. Keller RS, Jones JJ, Kim KF, et al. Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide? Shock 1995;4:338-44.
17. Decking UKM, Flesche CW, Gödecke A, Schrader J. Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide. Am J Physiol 1995;268:H2460-5.
18. Thoenes M, Förstermann U, Tracey WR, et al. Expression of inducible nitric oxide synthase in failing and non-failing human heart. J Mol Cell Cardiol 1996;28:165-9.
19. Yang X, Chowdhury N, Cai B, et al. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 1994;94:714-21.
20. Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996;93:720-9.
21. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992;89:6711-5.
22. Endres M, Laufs U, Merz H, Kaps M. Focal expression of intercellular adhesion molecule-1 in the human carotid bifurcation. Stroke 1997;28:77-82.
23. Geller DA, Lowenstein DJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-5.
24. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321:280-7.
25. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
26. de Belder AJ, Radomski MW, Why HJF, et al. Nitric oxide synthase activities in human myocardium. Lancet 1993;341:84-5.
27. Haywood GA, Philip ST, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-94.
28. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995;92:2198-203.
29. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumour necrosis factor-α. Br J Pharmacol 1995;114:27-34.
30. Weiss HR, Sadoff JD, Klabunde RE. Nitric oxide reduces myocardial contractility in isoproterenol-stimulated rat hearts by a mechanism independent of cyclic GMP or cyclic AMP. Pharmacology 1997;55:202-21.
31. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-6.
32. Beckman JS, Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 1993;21:330-4.
33. Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1994;308:89-95.
34. Oddis CV, Finkel M. Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac mycytes. Biochem Biophys Res Commun 1995;213:1002-9.
35. Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996;328:309-16.
36. Xie YW, Wolin MS. Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Circulation 1996;94:2580-6.
37. Xie YW, Kaminski PM, Wolin MS. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res 1998;82:891-7.
38. Szabo C, Salzman AL, Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett 1995;363:235-8.
39. Krishna CM, Liebmann JE, Kaufman D, et al. The catecholic metal sequestering agent 1,2-dihydroxybenzene-3,5-disulfonate confers protection against oxidative cell damage. Arch Biochem Biophys 1992;294:98-106.
40. Hamilton CA, Berg G, McIntyre M, McPhaden AR, Reid JL, Dominiczak AF. Effects of nitric oxide and superoxide on relaxation in human artery and vein. Atherosclerosis 1997;133:77-86.